That big grandfather clock in the library might be an impressive piece of mechanical ingenuity, and an even better example of fine cabinetry, but we’d expect that the accuracy of a pendulum timepiece ...

Merck & Co is planning to file a drug for unexplained or treatment-resistant cough after supportive results from two phase 3 trials. US-based Merck, known as MSD outside the US and Canada, said ...

Nine Java Enhancement Proposals make the final cut as OpenJDK shifts from feature development to bug fixing ahead of a September release.

Swedish biotech Calliditas has announced plans to file its rare disease drug Nefecon with the FDA early next year following positive results from a phase 3 clinical trial. The company has been ...

OpenAI has filed confidentially for an initial public offering (IPO), marking a significant milestone for the artificial intelligence company as it enters what its leaders describe as the "third phase ...